1. A set of integrated capacitor arrangements,
having at least two integrated capacitor arrangements, which have been produced in accordance with identical geometrical designs and which each contain a circuitry-effective main capacitor and at least one correction capacitor,
having an electrically conductive antifuse connection between the correction capacitor and the main capacitor in a first of the capacitor arrangements, the connection having been produced after the production of the main capacitor of the first capacitor arrangement,
having an electrically insulating antifuse interruption between the correction capacitor of the first capacitor arrangement and the main capacitor in a second of the capacitor arrangements, the interruption having been produced in accordance with the geometrical designs,
having at least one further correction capacitor in each capacitor arrangement,
having a further electrically conductive fuse connection between the further correction capacitor and the main capacitor in the first capacitor arrangement, the further connection having been produced in accordance with the geometrical designs, and
having a further electrically insulating fuse interruption between the further correction capacitor in the first capacitor arrangement and the main capacitor in the second capacitor arrangement, the interruption having been produced after production of the main capacitor of the second capacitor arrangement.
2. The capacitor arrangements as claimed in claim 1, wherein the connection and the interruption are situated at identical positions in the capacitor arrangements.
3. The capacitor arrangements as claimed in claim 1, wherein at least one of: the connection has been produced by local heating and the connection contains a material warpage which penetrates through a dielectric.
4. The capacitor arrangements as claimed in claim 1, wherein at least one of: a material covering the connection contains a cutout leading to the connection, a material covering the interruption contains a cutout leading to the interruption, and the cutouts are filled with a passivating material.
5. The capacitor arrangements as claimed in claim 1, wherein the further interruption arose as a result of local heating and vaporization of an electrically conducting section.
6. The capacitor arrangements as claimed in claim 1, wherein dielectrics of the capacitors have a thickness which is equal to a thickness of a dielectric between metallization layers in which connection sections of connections to integrated semiconductor components are situated.
7. The capacitor arrangements as claimed in claim 1, wherein at least one of: the capacitors have electrodes situated in more than two metallization layers, and the electrodes are formed in a whole-area or grid-like manner.
8. The capacitor arrangements as claimed in claim 1, wherein dielectrics of the capacitors have a thickness which is less than a thickness of a dielectric between metallization layers in which connection sections of connections to integrated semiconductor components are situated.
9. The capacitor arrangements as claimed in claim 1, wherein a capacitance of one of the correction capacitors amounts to less than \u2153 of a capacitance of the main capacitor to which the correction capacitor is connected.
10. A method for producing a set of integrated grid capacitors, the method comprising:
forming at least two integrated grid capacitors in accordance with identical geometrical designs, each grid capacitor containing a plurality of transverse electrodes forming a circuitry-effective main part of the grid capacitor,
forming at least two correction transverse electrodes arranged at identical positions in the grid capacitors to have circuitry-effective lengths of different magnitudes after the production of the main part, the circuitry-effective length of each correction transverse electrode that has been changed having been lengthened by production of an electrically conductive connection or having been shortened by at least one of an electrically insulating interruption and by vaporization of part of the correction transverse electrode, and, in a material covering the shortened correction transverse electrode, forming at least one cutout leading at least one of: to the shortened correction transverse electrode and to a region at which the shortened correction transverse electrode was arranged prior to the vaporization.
11. The method as claimed in claim 10, wherein the cutout is filled with a passivating material.
12. The method as claimed in claim 11, wherein a plurality of cutouts lead to a correction transverse electrode, or wherein one cutout which essentially covers the entire region of the original correction transverse electrode leads to a correction transverse electrode.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A solid composition for implantation into an animal comprising a first composition comprising at least one compound selected from the group consisting of a compound of the formula
wherein R is loweralkyl, the ester derivatives, geometric isomers, stereoisomers, or optical isomers thereof, a compound of the formula
wherein R1 and R2 are loweralkyl, the ester derivatives, geometric isomers, steroisomers, or optical isomers thereof, a compound of the formula
wherein R3 and R4 are loweralkyl, the geometric isomers, stereoisomers, optical isomers thereof, a compound of the formula
wherein R5 is loweralkyl, the ester derivatives, geometric isomers, stereoisomers, or optical isomers thereof, and a compound of the formula
wherein R6 is loweralkyl, the ester derivatives, geometric isomers, stereoisomers, or optical isomers thereof; and a second composition comprising at least one compound selected from the group consisting of a compound of the formula
wherein R is loweralkyl, the ester derivatives, geometric isomers, stereoisomers, or optical isomers thereof, a compound of the formula
wherein R1 and R2 are loweralkyl, the ester derivatives, geometric isomers, stereoisomers, or optical isomers thereof, a compound of the formula
Wherein R5 is loweralkyl, the ester derivatives, geometric isomers, stereoisomers, optical isomers thereof, a compound of the formula
Wherein R3 and R4 are loweralkyl, the geometric isomers, stereoisomers, or optical isomers thereof, and a compound of the formula
Wherein R6 is loweralkyl, the ester derivatives, geometric isomers, stereoisomers, or optical isomers thereof; and a biodegradable polymer selected from the group consisting of homopolymers and copolymers of \u03b3-butyrolactone, \u03b4-valerolactone, \u03b5-caprolactone, glycolide, DL-lactide, L-lactide, glycolic acid, DL-lactic acid, L-lactic acid, and combinations thereof, polydioxanones, polyorthesters, polyanhydrides, polycarbonates, polyesteramides, and polyphosphazines, wherein the second composition is coated on its surface with the biodegradable polymer whereby the release of its comprised compound is a delayed release in an in vivo environment such that the release of the compound of the second composition is delayed until at least about 35 days after placing the composition comprising the first composition and the second composition into an in vivo environment.
2. A composition according to claim 1 wherein R is methyl or the aroyl or alkanoyl ester derivatives thereof.
3. A composition according to claim 1 wherein R1 and R2 are methyl or the aroyl or alkanoyl ester derivatives thereof.
4. A composition according to claim 1 wherein R3 and R4 are methyl which is pregn-4-en-3,20-dione.
5. A composition according to claim 1 wherein R5 is methyl or the aroyl or alkanoyl ester derivatives thereof.
6. A composition according to claim 1 wherein R6 is methyl or the aroyl or alkanoly ester derivatives thereof.
7. The composition according to claim 2 wherein the compound is 17\u03b2-acetoxyestra-4,9,11-trien-3-one.
8. The composition according to claim 2 wherein the compound is 17\u03b2-benzoyloxoxyestra-4,9,11-trien-3-one.
9. The composition according to claim 3 wherein the compound is 17\u03b2-propionyloxy-4-androsten-3-one.
10. The composition according to claim 5 wherein the compound is estra-1,3,5(10)-trien-3,17\u03b2-diol.
11. The composition according to claim 5 wherein the compound is 17 \u03b2-benzoyloxyestra-1,3,5(10)-trien-3-ol.
12. The composition according to claim 6 wherein the compound is 3,4,5,6,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1-one.
13. A composition according to claim 1 wherein the biodegradable polymer is selected from the group consisting of homopolymers and copolymers of glycolide, DL-lactide, L-lactide, glycolic acid, DL-lactic acid and L-lactic acid and combinations thereof.
14. A composition according to claim 13 wherein the biodegradable polymer is a homopolymer selected from the group consisting of glycolide, DL-lactide and L-lactide.
15. The composition according to claim 13, wherein the biodegradable polymer is a copolymer of DL-lactide and glycolide.
16. The composition according to claim 13, wherein the biodegradable polymer is a copolymer of L-lactide and glycolide.
17. The composition according to claim 14 wherein the biodegradable polymer is a polymer of L-lactide.
18. The composition according to claim 14 wherein the biodegradable polymer is a polymer of DL-lactide.
19. A composition according to claim 13 wherein the homopolymer or copolymer exhibits a glass transition temperature greater than about 40\xb0 C.
20. A composition according to claim 13 wherein inherent viscosity of the polymers or copolymers is from about 0.1 dLg to about 3.5 dLg.
21. A composition according to claim 20 wherein the inherent viscosity is from about 0.3 dLg to about 1.5 dLg.
22. A composition according to claim 13 wherein the ratio of lactide units to glycolide units is from about 90:10 to about 50:50.
23. A composition according to claim 22 wherein the ratio of lactide units to glycolide units is from about 75:25 to about 60:40.
24. A weight gain composition comprising an excipient and as the active ingredient, a weight gain effective amount of a composition according to claim 1.
25. The composition according the claim 1, wherein the first composition and the second composition are each in the form of a pellet and wherein the length of the pellet is from about 3 mm to about 6 mm.
26. The composition according to claim 25 wherein the length of the pellet is from about 4 mm to about 5 mm.
27. The composition according to claim 26 wherein the length of the pellet is about 4.3 mm.
28. The composition according to claim 1, wherein the first composition and the second composition are each in the form of a pellet and wherein the diameter of the pellet is from about 2 mm to about 4 mm.
29. The composition according to claim 28 wherein the diameter of the pellet is from about 2.5 mm to about 3.5 mm.
30. The composition according to claim 29 wherein the diameter of the pellet is about 3.2 mm.
31. The composition according to claim 30 wherein the length of the pellet is about 4.3 mm and the diameter is about 3.2 mm.
32. The composition according to claim 1, wherein the first composition and the second composition are each in the form of a pellet and wherein the pellet contains from about 16 mg to about 24 mg of 17 \u03b2-acetoxyestra-4,9,11-trien-3-one.
33. The composition according to claim 32 wherein the pellet contains from about 19 mg to about 21 mg of 17 \u03b2-acetoxyestra-4,9,11-trien-3-one.
34. The composition according to claim 33 wherein the pellet contains about 20 mg of 17 \u03b2-acetoxyestra-4,9,11-trien-3-one.
35. The composition according to claim 34 wherein the pellet contains from about 2.0 mg to about 6.0 mg of estra-1,3,5(10)-trien-3,17 \u03b2-diol.
36. The composition according to claim 35 wherein the pellet contains from about 3.0 mg to about 5.0 mg of estra-1,3,5(10)-trien-3,17 \u03b2-diol.
37. The composition according to claim 36 wherein the pellet contains about 4.0 mg of estra-1,3,5(10)-trien-3,17 \u03b2-diol.
38. The solid composition for implantation according to claim 1, wherein the release of the at least one compound of the second composition is delayed until at least about 45 days after placing the composition into an in vivo environment.
39. The solid composition for implantation according to claim 1, wherein the release of the at least one compound of the second composition is delayed until at least about 55 days after placing the composition into an in vivo environment.
40. The solid composition for implantation according to claim 1, wherein the release of the at least one compound of the second composition is delayed until at least about 60 days after placing the composition into an in vivo environment.
41. The solid composition for implantation according to claim 1, wherein the release of the at least one compound of the second composition is delayed until at least about 70 days after placing the composition into an in vivo environment.
42. A method of promoting weight gain in a farm animal comprising a single administration to a farm animal of a weight gain effective amount of a solid composition according to claim 1, wherein the at least one compound of the first composition is available immediately on administration and the at least one compound of the second composition is available at a predetermined time controlled by the biodegradable polymer with which it is coated, said second composition not being available for at least about 35 days after being placed into an in vivo environment.
43. The method of claim 42, wherein the second composition is not available for at least about 45 days after being placed into an in vivo environment.
44. The method of claim 42, wherein the second composition is not available for at least about 55 days after being placed into an in vivo environment.
45. The method of claim 42, wherein the second composition is not available for at least about 60 days after being placed into an in vivo environment.
46. The method of claim 42, wherein the second composition is not available for at least about 70 days after being placed into an in vivo environment.
47. A solid composition for implantation into an animal comprising two compositions, wherein the first composition comprises at least one compound selected from the group consisting of a compound of the formula
wherein R is loweralkyl, the ester derivatives, geometric isomers, stereoismers, or optical isomers thereof, a compound of the formula
wherein R1 and R2 are loweralkyl, the ester derivatives, geometric isomers, stereoisomers, or optical isomers thereof, a compound of the formula
wherein R3 and R4 are loweralkyl, the geometric isomers, stereoisomers, optical isomers thereof, a compound of the formula
wherein R5 is loweralkyl, the ester derivatives, geometric isomers, stereoisomers, or optical isomers thereof, and a compound of the formula
wherein R6 is loweralkyl, the ester derivatives, geometric isomers, stereoisomers, or optical isomers thereof; and wherein the second composition, comprising at least one compound selected from the group consisting of a compound of the formula
wherein R is loweralkyl, the ester derivatives, geometric isomers, stereoisomers, or optical isomers thereof, a compound of the formula
wherein R1 and R2 are loweralkyl, the ester derivatives, geometric isomers, stereoisomers, or optical isomers thereof, a compound of the formula
wherein R3 and R4 are loweralkyl, the geometric isomers, stereoisomers, optical isomers thereof, a compound of the formula
wherein R5 is lower alkyl, the ester derivatives, geometric isomers, stereoisomers, or optical isomers thereof, and a compound of the formula
wherein R6 is loweralkyl, the ester derivatives, geometric isomers, stereoisomers, or optical isomers thereof; wherein the second composition is coated on its surface with a biodegradable polymer whereby its release is delayed at least 35 days in an in-vivo environment.
48. A method of promoting weight gain in a farm animal comprising a single administration to a farm animal of a weight gain effective amount of a solid composition according to claim 47, wherein the at least one compound of the first composition is available immediately on administration and the availability of at least one compound of the second composition is essentially delayed for at least 35 days.
49. The composition of claim 25, wherein the pellet has a beveled edge.
50. The composition of claim 28, wherein the pellet has a beveled edge.
51. The composition of claim 47, wherein the second composition further comprises a biodegradable polymer.
52. The composition of claim 1, wherein the first composition and the second composition further comprise a biodegradable polymer.
53. The composition of claim 47, wherein the first composition and the second composition further comprise a biodegradable polymer.